A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy

[1]  Guoping Zheng,et al.  E-Cadherin/β-Catenin Complex and the Epithelial Barrier , 2011, Journal of biomedicine & biotechnology.

[2]  F. Roviello,et al.  E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. , 2011, European journal of cancer.

[3]  J. Gu,et al.  Modulation of E-cadherin function and dysfunction by N-glycosylation , 2011, Cellular and Molecular Life Sciences.

[4]  R. Ribeiro,et al.  E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes , 2010, Journal of Clinical Pathology.

[5]  C. Caldas,et al.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research , 2010, Journal of Medical Genetics.

[6]  R. Seruca,et al.  E-cadherin mutations and cell motility: a genotype-phenotype correlation. , 2009, Experimental cell research.

[7]  G. Berx,et al.  The cell-cell adhesion molecule E-cadherin , 2008, Cellular and Molecular Life Sciences.

[8]  F. Roviello,et al.  E-cadherin and hereditary diffuse gastric cancer. , 2007, Surgery.

[9]  E. Parisini,et al.  The crystal structure of human E-cadherin domains 1 and 2, and comparison with other cadherins in the context of adhesion mechanism. , 2007, Journal of molecular biology.

[10]  B. Fernandez,et al.  Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. , 2007, JAMA.

[11]  B. Boman,et al.  Identification of seven novel germline mutations in the human E‐cadherin (CDH1) Gene , 2007, Human mutation.

[12]  R. Seruca,et al.  A model to infer the pathogenic significance of CDH1 germline missense variants , 2006, Journal of Molecular Medicine.

[13]  Hudson H. Freeze,et al.  Genetic defects in the human glycome , 2006, Nature Reviews Genetics.

[14]  Lian Zhang,et al.  CDH1 germline mutation in hereditary gastric carcinoma. , 2004, World journal of gastroenterology.

[15]  W. Foulkes,et al.  Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria , 2004, Journal of Medical Genetics.

[16]  H. Höfler,et al.  Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients , 2004, Journal of Medical Genetics.

[17]  D. Huntsman,et al.  E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. , 2003, Human molecular genetics.

[18]  Carla Oliveira,et al.  Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. , 2003, Human molecular genetics.

[19]  M. Wilkinson,et al.  Site-directed mutagenesis of large (13-kb) plasmids in a single-PCR procedure. , 2000, BioTechniques.

[20]  S. Ramesh,et al.  Reduction in membranous expression of β-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer , 1999, British Journal of Cancer.

[21]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[22]  Gerhard Christofori,et al.  A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.

[23]  Heinz Höfler,et al.  Mutations of the human E‐cadherin (CDH1) gene , 1998, Human mutation.

[24]  S. Jordan,et al.  Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. , 1997, Gastroenterology.

[25]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.